The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dokun, A. O.
Right arrow Articles by Yokoyama, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dokun, A. O.
Right arrow Articles by Yokoyama, W. M.
The Journal of Immunology, 2001, 167: 5286-5293.
Copyright © 2001 by The American Association of Immunologists

Analysis of In Situ NK Cell Responses During Viral Infection1

Ayotunde O. Dokun*, Dortha T. Chu{dagger}, Liping Yang{dagger}, Albert S. Bendelac{ddagger} and Wayne M. Yokoyama2,{dagger}

* Graduate School of Biological Sciences, Mechanisms of Disease and Therapy Program, Mt. Sinai School of Medicine, New York, NY 10029; {dagger} Howard Hughes Medical Institute, Rheumatology Division, Washington University School of Medicine, St. Louis MO 63110; and {ddagger} Department of Molecular Biology, Princeton University, Princeton, NJ 08544


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
NK cells are required for early control of murine CMV (MCMV) infection, but the distribution of murine NK cells in situ has not been clearly defined. We tested the reactivity of all available NK cell receptor-specific mAbs by immunohistochemistry. Only one mAb, 4D11 (anti-Ly-49G2), was reactive with C57BL/6 tissue sections. mAb 4D11-reactive cells expressed the nuclear morphology and flow cytometric profile of NK cells. In lymphoid organs, NK cells were distributed primarily in the splenic red pulp, between adjacent lobes in lymph node and randomly in the cortex and medulla of the thymus. No NK cells were detected in normal liver sections. Two days following MCMV infection, most splenic NK cells were associated with the lymphoid follicles and marginal zone. By day 3 following infection, the number of liver NK cells had increased significantly and the cells were detected within inflammatory foci. These changes were independent of IL-12, IFN-{gamma}, and TNF-{alpha}, as assessed in mice with targeted mutations. Concurrent immunostaining for NK cells and viral Ags revealed close association of NK cells and MCMV-infected cells in the spleen and liver. Similar results were obtained in CD1-/- and recombination activation gene-1-/- mice lacking NK T or T and B cells, respectively, indicating specificity of staining for NK cells. Thus, following MCMV infection, NK cells accumulate at sites of viral replication in an IL-12-, IFN-{gamma}-, and TNF-{alpha}-independent manner.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Natural killer cells are best known for their capacity to kill tumor targets (1, 2, 3). However, accumulating evidence indicate that NK cells are major components of the innate immune system. They appear to play a critical role in host anti-pathogen defense and may even regulate host adaptive immune responses (2, 3, 4). The function of NK cells is best exemplified during infection of mice with murine CMV (MCMV)3 (3, 5) that replicates within multiple organs including the liver and spleen (5). NK cells are required for early control of virus replication (6); this is achieved by a perforin-dependent mechanism in the spleen (7). Since perforin-dependent cytotoxicity requires close physical proximity between effector and targets (8), NK cell redistribution to the proximity of infected cells should be required for controlling viral replication.

The spleen (in rodents) and peripheral blood (in humans) are the primary sites from which NK cells are isolated for in vitro analysis, but they have also been detected in the lymph node, thymus, and nonlymphoid tissues including liver (2, 3). Unlike T and B cells, whose specific organization within lymphoid tissues is well characterized, NK cell distribution within lymphoid organs is less well known, particularly during infection. Although there have been attempts to define murine NK cell location in situ, these studies were compromised by the coexpression of the available serologic markers such as ASGM1 by other cell lineages, especially activated T cells (9, 10, 11). In cell transfer experiments bone marrow NK cells localize to areas within the spleen, where MCMV infected cells could also be detected (12), suggesting that NK redistribution to areas of infection may indeed occur. However, it is not clear whether such colocalization actually occurs in situ during infection or whether the observed effects reflect experimental cell trafficking. On the other hand, NK cell-mediated antiviral effects in the liver have been described as perforin-independent and IFN-{gamma}-dependent (7), suggesting that NK cell localization in the liver may be different from that in the spleen. Thus, the distribution of mouse NK cells in situ, either normally or in the context of pathologic processes, has not been clearly defined and may be helpful in understanding NK cell control of viral infections.

The recent progress in understanding NK cell receptors has provided new serologic tools to address the issue of NK cell localization. Some of these receptors, such as gp49, belong to the Ig superfamily and are expressed by all activated NK cells (13). However, gp49 molecules are not expressed on resting NK cells and are constitutively expressed by a wide variety of other cell lineages (13, 14), thus precluding them as useful markers of NK cells in situ. Most NK cells also express receptors belonging to the C-type lectin superfamily (15) that are encoded in the NK gene complex (NKC) (16). Whereas some members of this superfamily, e.g., NKR-P1, in particular NKR-P1c (NK1.1), may be expressed by all NK cells (16, 17), others, such as the Ly-49 receptors, are expressed by subsets (18). The Ly49 family of molecules includes the inhibitory receptors for MHC class I, Ly49A, Ly49C/I, and Ly49G2, and the related activating receptors, Ly49D and Ly49H (3). Unlike gp49, Ly49 receptors are stably expressed once the adult NK cell receptor repertoire has been developed (19), and their expression does not appear to be significantly altered upon NK cell activation (20). All these receptors can be detected with specific mAbs by flow cytometry (3), suggesting that they may be useful for in situ localization studies.

In this study we examined the reactivity of all available NK cell receptor-specific mAbs by immunohistochemistry (IHC). Only one mAb, 4D11, specific for Ly49G2, which is expressed by approximately 50% of splenic NK cells (21, 22), was reactive with C57BL/6 tissue sections. Using this mAb we determined the normal in situ distribution of NK cells in spleen, lymph node, and thymus. This afforded us the opportunity to study changes that occurred during MCMV infection, and we show that the number of NK cells within various tissues as well as their specific location change during infection. Moreover, we show that NK cells are in close physical proximity to infected cells in both spleen and liver in situ. Thus, these studies provide significant new insight into NK cell responses in vivo.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

The following mice were purchased from The Jackson Laboratory (Bar Harbor, ME): C57BL/6 (B6), B6-IL-12-/-, B6-IFN-{gamma}-/-, B6,129-TNF-{alpha}-/- (B6, 129-Tnftm1Gkl), B6,129SF2 (wild-type control for B6, 129-TNF-{alpha}-/-), and recombination activation gene (Rag)-1-deficient C57BL/6 (C57BL/6J-Rag-1-/-). C57BL/6-CD1-/- mice were previously generated in our laboratory (23). All mice contained the targeted allele on the C57BL/6 background and were housed in a pathogen-free barrier facility at Washington University. This facility is supervised by veterinarians; animal protocols have been approved by the animal studies committee at Washington University.

Virus and infections

Stocks of Smith strain MCMV (ATCC VR-194, lot 10; American Type Culture Collection, Manassas, VA) were generated from mouse salivary glands as previously described (24). Mice were infected on day 0 with 5 x 104 PFUs of MCMV via the i.p. route.

Abs and antiserum

The mAb 4D11 (rat IgG2a, anti-Ly-49G2) hybridoma is a kind gift from Dr. J. Ortaldo (National Cancer Institute, Frederick, MD), while mAb 270 (rat IgG2a anti-chicken neuronal receptor for acetylcholine) hybridoma was purchased from American Type Culture Collection. The following mAbs were purchased from BD PharMingen (San Diego, CA): APC-4D11, DX5 (anti-DX5), 2B4 (anti-2B4), 5E6 (anti-Ly49C/I), 4E5 (anti-Ly49D), PE-Gr-1 (anti-Ly6G), APC-2C11 (anti-CD3), and PE-PK136 (anti-NK1.1). FITC-4D11 was generated as previously described (25). Anti-MCMV antiserum was a gift from Dr. H. W. Virgin IV (Washington University School of Medicine, St. Louis, MO) (26).

Immunohistochemistry and immunocytochemistry

Spleens and livers were obtained from infected or uninfected mice at different days following infection, frozen in Tissue Freezing Medium (Triangle Biomedical Sciences, Durham, NC) on dry ice, and stored at -20 or -80°C until sectioning. Organs were sectioned at 5–10 µm using a Leica 1850 cryostat (Leica, Wetzlar, Germany) and stored at -20°C until used. Before staining, sections were allowed to equilibrate to room temperature, fixed in cold acetone, and rehydrated in PBS. Endogenous peroxidase was depleted by incubating sections for 10 min in 0.3% hydrogen peroxide in methanol. To reduce nonspecific staining 10% normal goat serum in PBS and avidin/biotin block (Vector Laboratories, Burlingame, CA) were applied to all sections before addition of Abs. For NK cell staining mAb 4D11 was incubated with sections for 1 h at room temperature or at 4°C overnight. Bound Abs were detected with HRP-conjugated goat anti-rat IgG (Jackson ImmunoResearch Laboratories, West Grove, PA). Staining was amplified using TSA Biotin System (New England Nuclear, Boston, MA) according to the manufacturer’s recommendations. This was followed by incubation with preformed complexes of avidin and biotin (Vector Laboratories) conjugated to HRP (Vectastain-ABC) or alkaline phosphatase (Vectastain-ABC-AP). Each incubation step was followed by three 5-min washes in PBS. The HRP substrate 3-amino-9-ethylcarbazole (AEC Substrate kit, Vector Laboratories) was used for deposition of red chromogen, while the alkaline phosphatase substrate, Vector substrate kit III (Vector Laboratories), was used for deposition of blue-purple chromogen. After sufficient chromogen deposition had been achieved, the reaction was stopped by washing the sections in running tap water. Sections were counterstained with hematoxylin, washed, and mounted with Crystal/Mount (Biomeda, Foster City, CA). In the experiments in which both NK cells and MCMV-infected cells were detected in the same section, NK cell staining was performed as described above, followed by blocking with 10% normal goat serum, then an overnight incubation with anti-MCMV immune sera (26). Bound Abs were detected with donkey anti-mouse IgG (Jackson ImmunoResearch Laboratories), and all other subsequent steps were performed as described above. mAb 270 was used as an isotype-matched control for 4D11 while nonimmune serum (26) was used as a control for the anti-MCMV immune serum. All mAbs and antiserum were diluted in 10% normal goat or donkey serum and used at concentrations previously determined to yield optimal staining.

To perform immunocytochemistry on sorted cells, cells were first applied to microscope slides by cytospin, then allowed to dry at room temperature for 10 min. Subsequently 4D11 staining was performed as described above for tissue sections. The nuclear morphology of sorted cells was determined by staining with KaryoMAX Giemsa (Invitrogen, Carlsbad, CA). All photomicrographs were acquired using a Nikon FDX-35 camera mounted on a Nikon Eclipse E400 microscope (Nikon, Tokyo, Japan).

Leukocyte isolation and determination of NK cell numbers

Leukocytes were isolated from liver, spleen, peripheral blood, and bone marrow as previously described (27, 28). The number of cells isolated from each tissue was determined by counting live cells using an hemocytometer. Dead cells were identified by trypan blue staining. The percentage of leukocytes that were CD3- NK1.1+ (NK cells) was determined by FACS analysis. The total number of NK cells was calculated by multiplying the percentage of NK cells by the number of leukocytes.

Flow cytometric analysis and sorting

Splenocytes were isolated from C57BL/6 mice as previously described (27, 28). Cells were resuspended in 2.4G2 (anti-Fc{gamma}RII/III) supernatant to block nonspecific binding through the FcR (29). Subsequently the desired fluorochrome conjugated mAbs were added at 1 µg/106 cells and incubated on ice for 30 min, then washed three times in wash solution. During FACS analysis, gates were set to exclude propidium iodide-positive (dead) cells. In cell sorting experiments cells were stained as described for flow cytometry, except that an unconjugated isotype matched mAb was substituted for 2.4G2 for blocking. Cells positive for the desired Ag were then sorted on a MoFlo cell sorter (Cytomation, Fort Collins, CO). The purity of sorted cells was determined by FACS analysis after sorting.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
mAb 4D11 specificity and reactivity in immunohistochemistry of C57BL/6 tissues

To determine the in situ distribution of NK cells, we analyzed the reactivity of mAbs specific for NK cell receptors by immunohistochemistry. These mAbs were either specific for receptors expressed by all NK cells, including DX5 (mAb DX5) (30), 2B4 (mAb 2B4) (31), and NK1.1 (mAb PK136) or receptors that are expressed by subsets of NK cells, e.g., Ly-49C/I (mAb 5E6), Ly-49D (mAb 4E5), Ly-49G2 (mAb 4D11), and Ly-49H (mAb 3D10). Preliminary experiments with a variety of immunohistochemical methods indicated that only one of the mAbs tested, 4D11, was reactive with C57BL/6 tissues (data not shown).

mAb 4D11 (anti-Ly-49G2) has been shown to react with approximately 50% of all splenic NK cells (NK1.1+ CD3-) by FACS analysis (20, 21). Only a minor population of 4D11+ cells (<10%) expresses the TCR/CD3 complex (21), and most of these are NK T cells (32) (our unpublished observations). However, less is known about mAb 4D11 reactivity with other leukocytes. We therefore evaluated 4D11+ splenocytes for expression of macrophage and neutrophil markers. As expected, these cells did not express the macrophage marker F4/80 (data not shown). Surprisingly, 4D11+ cells expressed Gr-1 (data not shown), a marker generally described as being neutrophil specific (33), suggesting that neutrophils may express Ly-49G2 or that NK cells may express Gr-1 at low levels. To address these possibilities, 4D11+ splenocytes were sorted and stained with Giemsa (Fig. 1GoB). 4D11+ cells displayed the nuclear morphology of lymphocytes and not that of neutrophils (Fig. 1GoB). This morphology was identical with that of sorted NK1.1+ CD3- cells representing NK cells (Fig. 1GoA). By contrast, sorted Gr-1high cells displayed the characteristic ringed polymorphonuclear (PMN) neutrophilic morphology (Fig. 1GoC). Thus, 4D11+ cells display the morphology of lymphocytes and not that of PMN cells.



View larger version (119K):
[in this window]
[in a new window]
 
FIGURE 1. mAb 4D11 is reactive in IHC and does not react with PMNs. Splenocytes from C57BL/6 mice were sorted with mAbs FITC-PK136 (anti-NK1.1, row A), APC-4D11 (anti-Ly-49G2, row B), or PE- Gr-1 (anti-Gr-1, row C). After sorting, each group of sorted cells was reanalyzed by flow cytometry (left column). Samples from each group of sorted cells were also stained with Giemsa as indicated to determine their nuclear morphology (magnification, x400). Immunohistochemistry was also performed on each group of sorted cells using mAb 4D11 or isotype control as indicated (magnification, x100).

 
Immunostaining with mAb 4D11 demonstrated reactivity with essentially all sorted 4D11+ cells, while isotype control mAb was not reactive (Fig. 1GoB). Approximately 50% of sorted NK1.1+ CD3- cells showed staining with mAb 4D11, consistent with results from flow cytometric analysis of the same population (Fig. 1GoA). By contrast, 4D11-stained cells were rare in the Gr-1-sorted population and most likely reflected rare contaminating NK cells from the sorting (Fig. 1GoC). Taken together with previous observations (21), mAb 4D11 appears to recognize bonafide NK cells and not other lineages. Importantly, it can be used in immunohistochemistry for identification of NK cells.

Normal distribution of NK cells in C57BL/6 mice

Although Ly-49G2 is expressed on approximately 50% of NK cells, this proportion appears to be stable on bulk NK cell populations in all tissues examined by flow cytometry (our unpublished observation). The ability to perform immunohistochemistry with mAb 4D11 therefore allowed us to assess the normal distribution of NK cells in mouse lymphoid organs and liver. Chromogen deposition on 4D11+ cells formed a circular pattern (Fig. 2GoA, inset), consistent with membrane expression of the Ly-49G2 receptor. In the spleen these NK cells were distributed primarily in the red pulp; however, an occasional NK cell could be found within lymphoid follicles (Fig. 2GoA, arrow). In the lymph node, NK cells were found primarily at the junction between adjacent lobes of the lymph node and within the T cell area (Fig. 2GoC). The B cell areas of the lymph node were generally devoid of NK cells (beyond the field of view in Fig. 2GoC). Unlike the spleen and lymph node, NK cells in the thymus were not localized to a particular region of the organ, but were randomly distributed in both the cortex and medulla (Fig. 2GoE). Interestingly, no NK cells were detected in the liver (data not shown), although NK1.1+ CD3- cells are easily detected by flow cytometry of liver cell suspensions (34).



View larger version (85K):
[in this window]
[in a new window]
 
FIGURE 2. Normal distribution of NK cells in spleen, lymph node, and thymus of C57BL/6 mice. Cryosections of spleen (A and B; magnification, x100), lymph node (C and D; magnification, x100), and thymus (E and F; magnification, x100) were stained with mAb 4D11 (A, C, and E) or an isotype-matched control mAb (B, D, and F). Red membrane staining shows NK cells, while blue counterstain (hematoxylin) shows cell nuclei. Asterisks indicate splenic red pulp (A), adjacent lobes of a lymph node (C), or thymic cortex (E), respectively. Insets show boxed areas in the figures (magnification, x200).

 
To confirm that the NK cell distribution pattern observed in wild-type C57BL/6 mice was not due to the minor population of NK T cells, tissues from CD1-/- mice that are deficient in NK T cells were analyzed, and a similar distribution pattern was found (data not shown). This suggests that the stained cells in C57BL/6 mice are primarily NK cells and not the minor population of NK T cells that are 4D11 reactive in flow cytometry of cell suspensions. Thus, in C57BL/6 mice NK cells are located primarily in the red pulp in spleen, between adjacent lobes in lymph node and randomly in the cortex and medulla of the thymus, but not in liver parenchyma.

NK cell distribution is altered during infection

Having established the normal distribution of NK cells in various organs, it was then possible to study alterations in these patterns during pathologic processes. Since NK cells are required for early control of MCMV replication, we sought to determine whether their distribution is altered during MCMV infection. C57BL/6 (resistant strain) mice were infected, and cryosections from spleen and livers were stained with mAb 4D11 on successive days following infection. At day 1 post infection the distribution of NK cells in spleen remained unchanged (Fig. 3GoA). However, by day 2 after infection the red pulp of the spleen became less cellular, and clusters of NK cells were found to be associated with the marginal zone and sinus area (Fig. 3GoC). An increase in the number of NK cells associated with lymphoid follicles was also observed (Fig. 3GoC). Analysis of day 3, 4, and 5 sections showed that NK cells were no longer associated with the marginal zone and sinus, with the pattern of distribution almost identical to that of an uninfected spleen (Fig. 3GoE). It is unlikely that these observed changes are due to effects of NK T cells, since similar observations were made in CD1-/- mice (Fig. 3GoG).



View larger version (103K):
[in this window]
[in a new window]
 
FIGURE 3. The distribution of splenic NK cells is altered during MCMV infection. Wild-type C57BL/6 (A–F) or CD1-/- (G and H) mice were infected with MCMV and sacrificed at different days following infection. Cryosections were generated from the spleens and stained with mAb 4D11 (left panels) or isotype-matched control mAb (right panels). Organs were analyzed on day 1 (A and B) day 2 (C, D, G, and H) or day 3 (E and F) following infection. Asterisks indicate the location of the red pulp, while arrows indicate NK cells around the marginal sinus (closed arrow) or within lymphoid follicles (open arrow). Similar changes were observed in both wild type (C and D) and CD1-/- mice (G and H). Magnification for all, x100.

 
In the liver NK cells were not detected in significant numbers until day 3 postinfection. At this point most cells were associated with inflammatory foci within the liver (Fig. 4Go, A and E). However, some cells were associated with blood vessels and hepatic sinusoids (Fig. 4GoA). On day 5 most NK cells in the liver remained associated with inflammatory foci (Fig. 4GoC). This is contrary to the spleen in which the NK cell distribution at this time point appears similar to that of an uninfected organ (data not shown). Analysis of Rag 1-/- and CD1-/- livers showed results similar to those of wild-type C57BL/6 mice, confirming that the stained cells were not T or NK T lymphocytes (Fig. 4Go, F and G).



View larger version (106K):
[in this window]
[in a new window]
 
FIGURE 4. NK cells associate with inflammatory foci in infected livers. Wild-type C57BL/6 (A–E), Rag 1-/- (F), and CD1-/- (G) mice were infected with MCMV and sacrificed at different days following infection. Cryosections of livers were generated and stained with mAb (A, C, and E–G). Sequential sections were stained with an isotype-matched control (B and D). A, B, and E–G, Staining of liver cryosections that were obtained 3 days following infection; C and D, staining of sections that were obtained after 5 days. Black arrows show red precipitate on 4D11+ NK cells (A, C, and E–G), while hematoxylin counterstain appears as blue. All panels are x100 magnification, while the inset in E is x200 showing the boxed area.

 
Changes in NK cell numbers in various compartments following infection

Inasmuch as 4D11-reactive cells were undetectable by IHC in uninfected liver, their appearance after infection could be due to an increase in the total number of NK cells associated with the liver or a selective change in the distribution of Ly49G2+ cells. To address these possibilities, we evaluated the total number of liver-associated NK cells in uninfected and infected mice by flow cytometry and cell count. On day 3 postinfection the percentage (Fig. 5GoA) and total number (Fig. 5GoB) of liver NK cells in infected mice were significantly increased compared with uninfected controls, whereas the percentage of Ly49G2+ cells was not markedly altered (Fig. 5GoC and data not shown). Thus, the capacity to detect previously undetectable 4D11+ NK cells in liver following infection may be due to an increase in the total number of NK cells within this tissue.



View larger version (37K):
[in this window]
[in a new window]
 
FIGURE 5. Alterations in NK cell numbers following MCMV infection. A, Flow cytometric analysis. Groups of mice either were not infected or were infected with MCMV, and leukocytes were isolated from their liver, spleen, peripheral blood, and bone marrow 3 days later. Typical dot plots obtained from flow cytometric analysis of liver and splenic leukocytes from uninfected and infected mice are indicated. The number in the upper left corner indicates the percentage of NK cells (NK1.1+ CD3-). Gates were set to exclude dead cells. B, Total number of NK cells. The total number of NK cells within each organ was determined, except in peripheral blood where the number shown is per milliliter. Each column represents the average number of NK cells from at least three different mice. C, Kinetic analysis of the change in NK cell numbers following infection. In a separate experiment the numbers of bulk NK and 4D11+ cells associated with the liver, spleen, and bone marrow of MCMV-infected mice were determined on different days following infection. At least three mice per group were used in each experiment. Day 0 indicates the average number of cells in uninfected mice. For some data points, error bars are not apparent because they are less than the size of the depicted symbol.

 
In light of the above observation we hypothesized that MCMV infection may result in corresponding changes in NK cells within other compartments. Contrary to the liver, the absolute number of NK cells in the spleen, peripheral blood, and bone marrow were somewhat reduced (Fig. 5Go, A and B) at day 3 postinfection. To better understand these results we analyzed the kinetics of the change in total NK and 4D11+ cell number in liver, spleen, and bone marrow NK cells. The results show a continuous increase in both bulk liver NK cells and 4D11+ cells throughout the duration of the study (6 days; Fig. 5GoC). The magnitude of increase in liver NK cells was nearly 5-fold by day 3 and 10-fold by day 6 (Fig. 5GoC). By contrast, only small changes were noted in the bone marrow, but the number of bone marrow NK cells remained at or below preinfection levels throughout the study (Fig. 5GoC). In the spleen the number of NK cells decreased initially and then increased as the infection progressed, reaching about a 2-fold increase by day 6 (Fig. 5GoC). The changes in NK cell number in the spleen were modest compared with those observed in the liver. While these changes could be due to trafficking, recruitment, or proliferation, these results nevertheless suggest that during MCMV infection, the distribution of NK cells favors their accumulation within the liver and spleen.

Role of cytokines in NK cell distribution

To address the mechanisms involved in the observed changes in NK cell distribution during MCMV infection, we investigated the role of certain cytokines that have been shown to affect NK cells. IL-12 administration has been shown to induce an IFN-{gamma}-dependent NK cell recruitment to liver in C57BL/6 mice (35). This is similar to the effect of poly(I:C) administration (36) that is blocked by anti-TNF-{alpha} antiserum (37). We therefore hypothesized that our observed changes during MCMV infection may be IL-12, IFN-{gamma}, or TNF-{alpha} dependent. Using gene-targeted mice we assessed the potential role of these cytokines in NK cell recruitment during infection. Following MCMV infection, livers from mutant and wild-type mice were analyzed to determine the number of NK cells associated with the tissue and compared with that in uninfected mice. To our surprise MCMV infection induced an increase in liver NK cells in all mutant and wild-type mice (Fig. 6Go). Therefore, the liver accumulation of NK cells during MCMV infection is independent of IL-12, IFN-{gamma}, or TNF-{alpha} alone.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 6. IL-12, IFN-{gamma}, and TNF-{alpha} were not required for NK cell recruitment to liver. The numbers of NK cells associated with the liver of IL-12 (A), TNF-{alpha} (B), and IFN-{gamma} (C) null mice were determined before and 3 days after infection as indicated. These numbers were then compared with those of age-matched wild-type mice. Each panel represents an independent experiment, and each column represents the average number of NK cells from at least three mice.

 
NK cells are in close proximity of infected cells

Perforin-mediated cytotoxicity requires physical interaction between effector and target cells (8). Since NK cell control of MCMV in the spleen is perforin dependent (7), close association between NK cells and virally infected cells should occur. Staining of sequential sections of the spleen for either MCMV or NK cells show that the distribution pattern of NK cells is similar to that of infected cells (Fig. 7Go, A and B), indicating that NK cells may colocalize with infected cells. Indeed, staining for both NK cells and MCMV-infected cells in the same section revealed that these cells were in close proximity, although not all NK cells were found in close proximity of virally infected cells (Fig. 7GoC). In the liver MCMV-infected cells were detected as clusters of two or more cells randomly distributed throughout the tissue (Fig. 7GoD). Some infected cells were associated with inflammatory foci (data not shown). As in the spleen, some NK cells could be found in the proximity of infected cells, although not all infected cells were found associated with NK cells (Fig. 7GoD). Thus, following MCMV infection NK cells show physical proximity with infected cells, especially in the spleen.



View larger version (133K):
[in this window]
[in a new window]
 
FIGURE 7. NK cells show close physical proximity with MCMV-infected cells in liver and spleen. A and B, Sequential sections of spleen from MCMV-infected mice stained for infected cells (A, red stain; magnification x100) or NK cells; (B, red stain; magnification, x100). Cryosections from infected spleen (day 2 following infection; C; magnification, x200) and liver (day 3 postinfection; D; magnification, x200) were stained for both infected cells (blue stain) and NK cells (red stain). Closed arrows indicate equivalent areas within the adjacent sections (A and B), while open arrows identify NK cells in close proximity to infected cells (C and D). In the spleen sections black asterisks indicate the locations of lymphoid follicles, and white asterisks indicate the locations of red pulp.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this study we have determined the normal distribution of murine NK cells in lymphoid organs using mAb 4D11 that is reactive with Ly49G2 expressed by about 50% of cells with the nuclear morphology and flow cytometric profile of NK cells. The distribution pattern of 4D11+ cells in various organs was the same in both NK T cell-sufficient C57BL/6 and deficient CD1-/- mice, indicating that the staining is reflective of NK cells rather than the minor population of NK T cells that are 4D11 reactive. Immunohistochemical staining showed that NK cells were located primarily in the red pulp in the spleen, between adjacent lobes of the lymph node and within the cortex and medulla in the thymus. Furthermore, we showed that during acute MCMV infection, the number of liver NK cells increases significantly, while only a small alteration in their numbers is seen in the spleen and bone marrow. Moreover, we demonstrate that NK cells redistribute from the splenic red pulp to the lymphoid follicle and marginal zone. Finally, we show that during MCMV infection NK cells show close proximity to infected cells in the spleen and liver, suggesting that they are physically positioned to effect lysis of infected cells.

The role of NK cells in the control of acute MCMV infection is now well established (38, 39). However, the details of NK cellular responses during infection have remained unclear because of the technical difficulties in identifying and tracking them in situ. The major effector functions of NK cells are cytokine secretion and direct cytotoxicity (3, 5); NK cells may therefore need to be located at sites of viral replication to perform these functions. The liver is a major site of viral replication during MCMV infection; accumulation of NK cells within this organ is consistent with the hypothesis that NK cells need to home to such a site to achieve their effector functions. Previous in situ analysis of cells associated with liver inflammation during MCMV infection show colocalization of ASGM1+ and MCMV-infected cells (40). However, the physical relationship between NK cells and MCMV-infected cells remained inconclusive, since cells of other lineages also express ASGM1, especially activated T cells (9, 10, 11). While this manuscript was in preparation, Andrews et al. (11) showed that NK cells in the liver do associate with MCMV-infected cells by direct immunofluorescent staining using PE-conjugated mAb PK136 (anti-NK1.1). However, this study was not able to determine histologic architecture and did not address changes in NK cell numbers in various compartments during infection. Here, we not only demonstrate that NK cells are found in close proximity of infected cells, but in addition we show that their numbers increase significantly in the liver, but not in spleen or bone marrow.

Surprisingly, we were unable to detect NK cells with 4D11 reactivity in uninfected liver tissues. Yet, NK cells can be easily isolated from single cell suspensions of leukocytes from this organ. It is possible that in uninfected livers, NK cells are resident within the blood vasculature and are washed away during the sample preparation, whereas they are retained in infected livers due to infiltration of the parenchyma. Alternatively, the density of NK cells in the liver may be too low to detect, since there are approximately 103-fold more NK cells per gram of uninfected tissue in spleen compared with liver (our unpublished observation), and subsequently, reflecting at least a 5-fold increase in liver NK cells, they can be visualized by immunohistochemistry. Interestingly the number of NK cells in the spleen decreases initially during infection. Although this could be due to other mechanisms, including cell death, the subsequent increase in liver NK cells suggests that recruitment to the liver may have occurred. Alternatively, it is possible that 4D11 staining is present in infected livers due to up-regulation of Ly49G2 expression. This seems unlikely, since the percentage of 4D11+ cells remains relatively constant during infection, and the level of Ly49G2 expression is comparable in liver and spleen by FACS. Taken together, while we cannot rule out the possibility that other factors may have contributed to our ready detection of NK cells in infected livers, the observed increase in the total number of NK cells associated with the liver as well as an increase in the number of NK cells in the parenchyma may have contributed to the immunohistochemical detection of NK cells in infected liver.

NK cell responses are differentially regulated among organs. For instance, during MCMV infection perforin-dependent mechanisms are required for control of viral replication in the spleen, but not in the liver (7), suggesting a critical role for granule-mediated cytotoxicity. Conversely, IFN-{gamma} appears to be critical for MCMV clearance in the liver (5, 7). Furthermore, the effect of Cmv1, a previously described autosomal dominant genetic locus controlling MCMV replication, is primarily mediated in the spleen (41). Our analyses of uninfected spleens show that NK cells were located primarily in the red pulp. Inasmuch as the blood circulation in the red pulp is open (42), NK cells are positioned to directly interact with contents of the blood or to respond to products secreted by red pulp macrophages that are part of the reticulo-endothelial system (42). Following MCMV infection there was an alteration in the normal NK cell distribution pattern. In marked contrast to uninfected spleens, the red pulp was practically devoid of NK cells. Furthermore, the lymphoid follicle and marginal zone areas, which rarely contained NK cells in uninfected spleen, had an accumulation of these cells. This was not surprising, since previous studies as well as our own observations revealed that cells in the marginal zone are the predominant MCMV-infected cells in the spleen (11, 43). Here we clearly show that some splenic NK cells are in physical proximity to infected cells, consistent with a role for cytotoxicity in NK cell-mediated resistance to MCMV. As mentioned earlier, not all detected NK cells were associated with virally infected cells, suggesting that NK cells may be heterogeneous in their response to infection with only specific subsets involved in viral clearance. Interestingly, we recently identified Ly-49H as an NK cell activation receptor that mediates resistance to MCMV (44). NK cell subsets expressing this receptor may therefore respond differently than others. While the mAb to Ly49H (3D10) has not been useful in immunohistochemistry (our unpublished observation), it is interesting to note that approximately 60% of the 4D11-reactive cells express Ly49H (20). In conclusion, our current data establish the normal distribution of NK cells in lymphoid organs and clarify their physical relationship to infected cells in the spleen.

IL-12, IFN-{gamma}, and TNF-{alpha} were previously implicated in induction of NK cell accumulation in liver (35, 36). Since these cytokines are secreted during MCMV infection (45, 46), we assessed their role in mediating our observed increase in liver NK cell numbers during infection. To our surprise the increase in the number of liver NK cells was independent of each individual cytokine. This may be due to a redundancy in the mechanisms involved in NK cell recruitment. In MCMV infection a multitude of cytokines is produced. Any one alone may be able to induce an increase in the number of liver NK cells. Alternatively, the increase in NK cell number may be chemokine mediated, since NK cells can respond to several chemokines in vitro, including RANTES, macrophage inflammatory protein-1{alpha} (MIP-1{alpha}), MIP-1{beta}, macrophage chemoattractant protein-1 (MCP-1), and MCP-2 (47). However, the physiological role of these chemokines in NK cell recruitment is not well understood. Recently, it was shown that the recruitment of NK cells to the liver during MCMV infection was abrogated in MIP-1{alpha}-/- mice (40), suggesting that MIP-1{alpha}-/- may be required for NK cell recruitment and that NK cell recruitment is needed for protection. It is important to note, however, that no inflammation could be detected in the liver of the MIP-1{alpha}-/- mice. This suggests that MIP-1{alpha} may not be specifically required for NK cell recruitment, but may instead be a more general proinflammatory chemokine; the lack of NK cells may therefore be an indirect effect.

Thus, the current studies indicate the in situ localization of NK cells and provide valuable insight into understanding the role of NK cells during infection.


    Acknowledgments
 
We thank Dr. Herbert Virgin for advice on MCMV infections and for providing antiserum to MCMV and initial viral stocks. We thank Dr. Robin Lorenz and Steve Martin for sharing their expertise in immunohistochemistry. We also thank Dr. Jonathan Heusel for critical evaluation of this manuscript and Dr. John Ortaldo for the 4D11 hybridoma.


    Footnotes
 
1 This work was supported by grants from the National Institutes of Health (to W.M.Y., who is an investigator with the Howard Hughes Medical Institute). Back

2 Address correspondence and reprint requests to Dr. Wayne M. Yokoyama, Rheumatology Division, Box 8045, Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110. E-mail address: yokoyama{at}imgate.wustl.edu Back

3 Abbreviations used in this paper used in this paper: MCMV, murine CMV; ASGM1, asialo ganglio-N-tetraoglyceramide; NKC, NK gene complex; MIP-1, macrophage inflammatory protein-1{alpha}; MCP-1, macrophage chemoattractant protein-1; MCP-2, macrophage chemoattractant protein-2; PMN, polymorphonuclear; Rag, recombination activation gene; IHC, immunohistochemistry. Back

Received for publication May 14, 2001. Accepted for publication August 21, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Kim, S., W. M. Yokoyama. 1998. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement. Cell. Immunol. 183:106.[Medline]
  2. Trinchieri, G.. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.[Medline]
  3. Yokoyama, W. M.. 1999. Natural killer cells. W. E. Paul, ed. Fundamental Immunology, Chapter 17. 575. Lippincott-Raven, Philadelphia.
  4. Biron, C. A., H. C. Su, J. S. Orange. 1996. Function and regulation of natural killer (NK) cells during viral infections: characterization of responses in vivo. Methods 9:379.[Medline]
  5. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189.[Medline]
  6. Bukowski, J. F., B. A. Woda, R. M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52:119.[Abstract/Free Full Text]
  7. Tay, C. H., R. M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267.[Abstract]
  8. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207.[Medline]
  9. Kasai, M., M. Iwamori, Y. Nagai, K. Okumura, T. Tada. 1980. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10:175.[Medline]
  10. Stitz, L., J. Baenziger, H. Pircher, H. Hengartner, R. M. Zinkernagel. 1986. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. J. Immunol. 136:4674.[Abstract]
  11. Andrews, D. M., H. E. Farrell, E. H. Densley, A. A. Scalzo, G. R. Shellam, M. A. Degli-Esposti. 2001. NK1.1+ cells and murine cytomegalovirus infection: what happens in situ?. J. Immunol. 166:1796.[Abstract/Free Full Text]
  12. Salazar-Mather, T. P., R. Ishikawa, C. A. Biron. 1996. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J. Immunol. 157:3054.[Abstract]
  13. Wang, L. L., D. T. Chu, A. O. Dokun, W. M. Yokoyama. 2000. Inducible expression of the gp49B inhibitory receptor on NK cells. J. Immunol. 164:5215.[Abstract/Free Full Text]
  14. Castells, M. C., X. Wu, J. P. Arm, K. F. Austen, H. R. Katz. 1994. Cloning of the gp49B gene of the immunoglobulin superfamily and demonstration that one of its two products is an early-expressed mast cell surface protein originally described as gp49. J. Biol. Chem. 269:8393.[Abstract/Free Full Text]
  15. Yokoyama, W. M.. 1993. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol. 11:613.[Medline]
  16. Yokoyama, W. M.. 1999. Natural Killer Cells and the NK Gene Complex Blackwell, London.
  17. Koo, G. C., J. R. Peppard. 1984. Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma 3:301.[Medline]
  18. Yokoyama, W. M.. 1995. Right-side-up and up-side-down NK-cell receptors. Curr. Biol. 5:982.[Medline]
  19. Dorfman, J. R., D. H. Raulet. 1998. Acquisition of Ly49 receptor expression by developing natural killer cells. J. Exp. Med. 187:609.[Abstract/Free Full Text]
  20. Smith, H. R., H. H. Chuang, L. L. Wang, M. Salcedo, J. W. Heusel, W. M. Yokoyama. 2000. Nonstochastic coexpression of activation receptors on murine natural killer cells. J. Exp. Med. 191:1341.[Abstract/Free Full Text]
  21. Mason, L., S. L. Giardina, T. Hecht, J. Ortaldo, B. J. Mathieson. 1988. LGL-1: a non-polymorphic antigen expressed on a major population of mouse natural killer cells. J. Immunol. 140:4403.[Abstract]
  22. Mason, L. H., J. R. Ortaldo, H. A. Young, V. Kumar, M. Bennett, S. K. Anderson. 1995. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). J. Exp. Med. 182:293.[Abstract/Free Full Text]
  23. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, A. Bendelac. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647.[Abstract/Free Full Text]
  24. Heise, M. T., H. W. I. Virgin. 1995. The T-cell-independent role of {gamma} interferon and tumor necrosis factor {alpha} in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:904.[Abstract]
  25. Coligan, J. E. A. M. K., D. H. Margulies, E. M. Shevach, and W. Strober. 1996. Current Protocols in Immunology. Wiley, New York, p. 8:1.1.
  26. Presti, R. M., J. L. Pollock, A. J. Dal Canto, A. K. O’Guin, H. W. I. Virgin. 1998. Interferon {gamma} regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J. Exp. Med. 188:577.[Abstract/Free Full Text]
  27. Takahashi, M., K. Ogasawara, K. Takeda, W. Hashimoto, H. Sakihara, K. Kumagai, R. Anzai, M. Satoh, S. Seki. 1996. LPS induces NK1.1+ {alpha}{beta} T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J. Immunol. 156:2436.[Abstract]
  28. Karlhofer, F. M., W. M. Yokoyama. 1991. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen: IL-2-activated NK cells possess additional specific stimulation pathways. J. Immunol. 146:3662.[Abstract]
  29. Unkeless, J. C.. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.[Abstract/Free Full Text]
  30. Ortaldo, J. R., R. Winkler-Pickett, A. T. Mason, L. H. Mason. 1998. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells. J. Immunol. 160:1158.[Abstract/Free Full Text]
  31. Sentman, C. L., Jr J. Hackett, T. A. Moore, M. M. Tutt, M. Bennett, V. Kumar. 1989. Pan natural killer cell monoclonal antibodies and their relationship to the NK1.1 antigen. Hybridoma 8:605.[Medline]
  32. Mason, L. H., B. J. Mathieson, J. R. Ortaldo. 1990. Natural killer (NK) cell subsets in the mouse. NK-1.1+/LGL-1+ cells restricted to lysing NK targets, whereas NK-1.1+/LGL-1- cells generate lymphokine-activated killer cells. J. Immunol. 145:751.[Abstract]
  33. Lagasse, E., I. L. Weissman. 1996. Flow cytometric identification of murine neutrophils and monocytes. J. Immunol. Methods 197:139.[Medline]
  34. Kim, S., K. Iizuka, H. L. Aguila, I. L. Weissman, W. M. Yokoyama. 2000. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc. Natl. Acad. Sci. USA 97:2731.[Abstract/Free Full Text]
  35. Fogler, W. E., K. Volker, M. Watanabe, J. M. Wigginton, P. Roessler, M. J. Brunda, J. R. Ortaldo, R. H. Wiltrout. 1998. Recruitment of hepatic NK cells by IL-12 is dependent on IFN-{gamma} and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas. J. Immunol. 161:6014.[Abstract/Free Full Text]
  36. Wiltrout, R. H., A. M. Pilaro, M. E. Gruys, J. E. Talmadge, D. L. Longo, J. R. Ortaldo, C. W. Reynolds. 1989. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow. J. Immunol. 143:372.[Abstract]
  37. Pilaro, A. M., D. D. Taub, K. L. McCormick, H. M. Williams, T. J. Sayers, W. E. Fogler, R. H. Wiltrout. 1994. TNF-{alpha} is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J. Immunol. 153:333.[Abstract]
  38. Welsh, R. M., C. L. O’Donnell, L. D. Shultz. 1994. Antiviral activity of NK 1.1+ natural killer cells in C57BL/6 scid mice infected with murine cytomegalovirus. Nat. Immun. 13:239.[Medline]
  39. Biron, C. A.. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24.[Medline]
  40. Salazar-Mather, T. P., J. S. Orange, C. A. Biron. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1{alpha} (MIP-1{alpha})-dependent pathways. J. Exp. Med. 187:1.[Abstract/Free Full Text]
  41. Scalzo, A. A., N. A. Fitzgerald, A. Simmons, A. B. La Vista, G. R. Shellam. 1990. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171:1469.[Abstract/Free Full Text]
  42. Kraal, G.. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31.[Medline]
  43. Stoddart, C. A., R. D. Cardin, J. M. Boname, W. C. Manning, G. B. Abenes, E. S. Mocarski. 1994. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68:6243.[Abstract/Free Full Text]
  44. Brown., M. G., A. O. Dokun, J. W. Heusel, H. R. C. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292:934.[Abstract/Free Full Text]
  45. Biron, C. A.. 1994. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr. Opin. Immunol. 6:530.[Medline]
  46. Biron, C. A., R. T. Gazzinelli. 1995. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7:485.[Medline]
  47. Maghazachi, A. A., A. Al-Aoukaty. 1998. Chemokines activate natural killer cells through heterotrimeric G-proteins: implications for the treatment of AIDS and cancer. FASEB J. 12:913.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
P. Jennings and D. Yuan
NK Cell Enhancement of Antigen Presentation by B Lymphocytes
J. Immunol., March 1, 2009; 182(5): 2879 - 2887.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Giroux, E. Yurchenko, J. St.-Pierre, C. A. Piccirillo, and C. Perreault
T Regulatory Cells Control Numbers of NK Cells and CD8{alpha}+ Immature Dendritic Cells in the Lymph Node Paracortex
J. Immunol., October 1, 2007; 179(7): 4492 - 4502.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S.-R. Chang, K.-J. Wang, Y.-F. Lu, L.-J. Yang, W.-J. Chen, Y.-H. Lin, H.-H. Chang, and S.-L. Wang
Characterization of Early Gamma Interferon (IFN-{gamma}) Expression during Murine Listeriosis: Identification of NK1.1+ CD11c+ Cells as the Primary IFN-{gamma}-Expressing Cells
Infect. Immun., March 1, 2007; 75(3): 1167 - 1176.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Walzer, M. Blery, J. Chaix, N. Fuseri, L. Chasson, S. H. Robbins, S. Jaeger, P. Andre, L. Gauthier, L. Daniel, et al.
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46
PNAS, February 27, 2007; 104(9): 3384 - 3389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Qian, X. Jiang, H. An, Y. Yu, Z. Guo, S. Liu, H. Xu, and X. Cao
TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation
Blood, October 1, 2006; 108(7): 2307 - 2315.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Bajenoff, B. Breart, A. Y.C. Huang, H. Qi, J. Cazareth, V. M. Braud, R. N. Germain, and N. Glaichenhaus
Natural killer cell behavior in lymph nodes revealed by static and real-time imaging
J. Exp. Med., March 20, 2006; 203(3): 619 - 631.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A.-C. Iversen, P. S. Norris, C. F. Ware, and C. A. Benedict
Human NK Cells Inhibit Cytomegalovirus Replication through a Noncytolytic Mechanism Involving Lymphotoxin-Dependent Induction of IFN-{beta}
J. Immunol., December 1, 2005; 175(11): 7568 - 7574.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Baratin, S. Roetynck, C. Lepolard, C. Falk, S. Sawadogo, S. Uematsu, S. Akira, B. Ryffel, J.-G. Tiraby, L. Alexopoulou, et al.
Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum
PNAS, October 11, 2005; 102(41): 14747 - 14752.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. E. Berg, E. Crossley, S. Murray, and J. Forman
Relative Contributions of NK and CD8 T Cells to IFN-{gamma} Mediated Innate Immune Protection against Listeria monocytogenes
J. Immunol., August 1, 2005; 175(3): 1751 - 1757.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. H. Robbins, M. S. Tessmer, T. Mikayama, and L. Brossay
Expansion and Contraction of the NK Cell Compartment in Response to Murine Cytomegalovirus Infection
J. Immunol., July 1, 2004; 173(1): 259 - 266.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. J. Roberts, Y. Lin, P. M. Spence, L. Van Kaer, and R. R. Brutkiewicz
CD1d1-Dependent Control of the Magnitude of an Acute Antiviral Immune Response
J. Immunol., March 15, 2004; 172(6): 3454 - 3461.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. P. Makrigiannis, E. Rousselle, and S. K. Anderson
Independent Control of Ly49g Alleles: Implications for NK Cell Repertoire Selection and Tumor Cell Killing
J. Immunol., February 1, 2004; 172(3): 1414 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Friese, M. Platten, S. Z. Lutz, U. Naumann, S. Aulwurm, F. Bischof, H.-J. Buhring, J. Dichgans, H.-G. Rammensee, A. Steinle, et al.
MICA/NKG2D-Mediated Immunogene Therapy of Experimental Gliomas
Cancer Res., December 15, 2003; 63(24): 8996 - 9006.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. A. Rabinovich, J. Li, J. Shannon, R. Hurren, J. Chalupny, D. Cosman, and R. G. Miller
Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells
J. Immunol., April 1, 2003; 170(7): 3572 - 3576.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. S. Falk, M. Mach, D. J. Schendel, E. H. Weiss, I. Hilgert, and G. Hahn
NK Cell Activity During Human Cytomegalovirus Infection Is Dominated by US2-11-Mediated HLA Class I Down-Regulation
J. Immunol., September 15, 2002; 169(6): 3257 - 3266.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dokun, A. O.
Right arrow Articles by Yokoyama, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dokun, A. O.
Right arrow Articles by Yokoyama, W. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS